Top rated US pharmaceutical company Pfizer launched a ¥60bn seven year global bond yesterday (Thursday), its debut transaction in the international capital markets, the company having previously relied on the US markets for funding. The deal, which matures on March 20, 2008, will be priced today (Friday) at a spread of 7bp area over the JGB 2001 by joint bookrunners Merrill Lynch and Morgan Stanley. Proceeds are to refund short term debt and are reportedly being retained in yen with no swap involved.
May 11, 2001